Commerce Bank’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Commerce Bank’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1	Closed	-$1K	–	939
2019 Q1	$1K	Hold	1	–	–	﹤0.01%	881
2018 Q4	$1K	Hold	1	–	–	﹤0.01%	851
2018 Q3	$2K	Hold	1	–	–	﹤0.01%	869
2018 Q2	$2K	Hold	1	–	–	﹤0.01%	857
2018 Q1	$2K	Hold	1	–	–	﹤0.01%	837
2017 Q4	$1K	Hold	1	–	–	﹤0.01%	832
2017 Q3	$3K	Hold	1	–	–	﹤0.01%	820
2017 Q2	$5K	Buy	+1	New	+$8.71K	﹤0.01%	823

Other funds holding TMBR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFG

Nadler Financial Group Deerfield, Illinois $1.04B AUM 19.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Commerce Bank's TMBR Position: Q2 2019 in Review

Commerce Bank sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2019, closing a stake of 1 share — an estimated $1K sold.

Commerce Bank first reported a position in TMBR in Q2 2017 and held it in 8 quarters. The position peaked at $5K in Q2 2017. 14 funds tracked by Wall St. Rank hold TMBR as of Q2 2019.

Commerce Bank reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Commerce Bank sold 1 Timber Pharmaceuticals, Inc. share in Q2 2019, an estimated $1K.
Commerce Bank first reported a position in Timber Pharmaceuticals, Inc. in Q2 2017 and held it in 8 quarters.
Commerce Bank's Timber Pharmaceuticals, Inc. position peaked at $5K in Q2 2017.
14 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2019.

Based on Commerce Bank's 13F filing for Q2 2019, filed 7 Aug 2019.